Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05459298 · ClinicalTrials.gov registry record · NA
ViDES Trial (Vitamin D Extra Supplementation)
A NA study of Vitamin D Deficiency, sponsored by The University of Texas Health Science Center, Houston.
- Active
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05459298: Active NA study of Vitamin D Deficiency, sponsored by The University of Texas Health Science Center, Houston.
NCT05459298 is a NA study of Vitamin D Deficiency that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 180 participants, below the 272-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05459298, a NA study of Vitamin D Deficiency, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to compare supplementation with vitamin D at 800 IU/day to usual care for the first 28 days after birth with respect to 25 (OH) vitamin D levels and indicators of likely or plausible effects of vitamin D supplementation on the function or structure of the lung, bones, immune system, and brain in extremely premature (EP) infants who are \<28 weeks gestational age (GA) or \<1000 grams of birth weight (BW). The study results will be analyzed as intention to treat Bayesian analyses (Frequentist analyses will also be performed).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- OTHER Usual Care
- DIETARY_SUPPLEMENT 800 IU/day vitamin D supplementation with feedings in the first 28 days after birth
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What the registry record for NCT05459298 still lists
NCT05459298 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (34% lower).
The record links to 1 condition, with Vitamin D Deficiency appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05459298 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05459298 about?
NCT05459298 is a clinical study titled "ViDES Trial (Vitamin D Extra Supplementation)". The objective of the study is to compare supplementation with vitamin D at 800 IU/day to usual care for the first 28 days after birth with respect to 25 (OH) vitamin D levels and indicators of likely or plausible effects of vitamin D supplementation on the function or structure of the lung, bones, i...
What is the current status of trial NCT05459298?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2022-09-06. Estimated completion is 2027-12-01.
What conditions does trial NCT05459298 study?
This clinical trial studies the following conditions: Vitamin D Deficiency.
What interventions are being tested in trial NCT05459298?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Usual Care (OTHER), 800 IU/day vitamin D supplementation with feedings in the first 28 days after birth (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05459298?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05459298 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitamin D Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05459298's enrollment target sits among peer trials
180 8th of 48 higher than 40 of 48 other Vitamin D Deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vitamin D Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight
RECRUITING · NA
-
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
RECRUITING · NA
-
Vitamin D Sulfates in Breastmilk
ACTIVE NOT RECRUITING · NA
-
Vitamin D and Adipose Tissue Inflammation
COMPLETED · NA
-
Vitamin D Levels and Vitamin D Education in Geriatric Patients
COMPLETED · NA
-
Vitamin D Replacement Using Oral Thin Film (OTF) Cholecalciferol in Patients Undergoing Hematopoietic Stem Cell Transplantation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI